2-氨基-3-甲基苯甲醇 | 57772-50-6

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 氨基醇类衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氨基-3-甲基苯甲醇
• 中文别名: 2-氨基-3-甲基苄醇
• 英文名称: 2-amino-3-methylbenzyl alcohol
• 英文别名: (2-amino-3-methylphenyl)methanol；3-methyl-2-aminobenzyl alcohol
• CAS: 57772-50-6
• 化学式: C₈H₁₁NO
• 分子量: 137.181
• InChiKey: FWTCWZZOKOBJIR-UHFFFAOYSA-N

物化性质

• 熔点：
  67-69 °C (lit.)
• 沸点：
  135-145℃ (12 Torr)
• 密度：
  1.126±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿（少许）
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  46.2
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  2922199090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  保持贮藏器密封，并将其放入一个紧密封装的容器中。应存放在阴凉、干燥的地方。

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 2-Amino-3-methylbenzyl alcohol
CAS-No. : 57772-50-6
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Skin irritation (Category 2)
Eye irritation (Category 2)
Specific target organ toxicity - single exposure (Category 3)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Irritating to eyes, respiratory system and skin.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Warning
Hazard statement(s)
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
Precautionary statement(s)
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R36/37/38 Irritating to eyes, respiratory system and skin.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
S37/39 Wear suitable gloves and eye/face protection.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C8H11NO
Molecular Weight : 137,18 g/mol
Component Concentration
2-Amino-3-methylbenzyl alcohol
CAS-No. 57772-50-6 -

---

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
Absorption into the body leads to the formation of methemoglobin which in sufficient concentration causes
cyanosis. Onset may be delayed 2 to 4 hours or longer., To the best of our knowledge, the chemical,
physical, and toxicological properties have not been thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 67 - 69 °C - lit.
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. Causes respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. Causes skin irritation.
Eyes Causes serious eye irritation.
Signs and Symptoms of Exposure
Absorption into the body leads to the formation of methemoglobin which in sufficient concentration causes
cyanosis. Onset may be delayed 2 to 4 hours or longer., To the best of our knowledge, the chemical,
physical, and toxicological properties have not been thoroughly investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine Pollutant: no IATA: no
Special precautions for user
no data available

---

---

SECTION 15 - REGULATORY INFORMATION
N/A

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氨基-3-甲基苯甲醇 在 manganese(IV) oxide 、 chloro[1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]copper(I) 、 sodium t-butanolate 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 生成 2,8-二甲基喹啉
  参考文献：
  名称：

  喹啉和萘啶的合成通过与β羟基酮的催化逆向醛醇缩合反应的邻-aminobenzaldehydes或nicotinaldehydes †

  摘要：

  据报道，Cu（I）催化β-羟基酮与邻氨基苯甲醛和烟醛的逆醛醇缩合反应，可高效，高选择性地产生一系列喹啉和萘啶。该反应使用的β-羟基酮，为区域专一酮保护的烯醇化物源通过铜催化复古醛醇Ç α -C β键裂解。在现场与生成的铜烯醇经历动力学有利环邻-氨基芳基醛以化学和区域选择性方式产生喹啉和萘啶。温和的和弱碱性的反应条件还抑制了强碱性条件下苯甲醛可能发生的副反应，从而提高了反应产率。

  DOI：

  10.1039/c6ob01452f
• 作为产物：
  描述：

  2-氨基-3-甲基苯甲酸 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 生成 2-氨基-3-甲基苯甲醇
  参考文献：
  名称：

  利用化学电离质谱和稳定同位素标记对利多卡因和几种代谢物进行定量

  摘要：

  使用直接插入探针和化学电离质谱法对可疑的利多卡因代谢产物进行定量。将利多卡因代谢物的氘代类似物添加至系列人血浆和尿液样本中，并在将250 mg盐酸利多卡因一水合物口服给予两名男性受试者和将202 mg利多卡因游离碱给予一名男性受试者后，用作内标。经过0-24小时尿液样品分析后的平均结果，在用β-葡萄糖醛酸苷酶-硫酸酯酶处理之前，表明存在以下量的7种可能的代谢产物（基于游离碱的给药剂量百分比）：利多卡因1.95 ; ω-乙基氨基-2,6-二甲基乙酰苯胺，4.90; ω-氨基-2,6-二甲基乙酰苯胺，0.88; 间羟基和/或对羟基利多卡因，0.73; 间和/或对羟基-ω-乙基氨基-2,6-二甲基乙酰苯胺，0.56; 2,6-二甲基苯胺，0.97; 和4-羟基-2，6-二甲基苯胺63.5。在人和恒河猴的尿液中均检测到N-乙基和N，N-二乙基甘氨酸，尽管未实现定量。

  DOI：

  10.1002/jps.2600660834

文献信息

• 腺苷受体拮抗剂
  申请人：厦门宝太生物科技股份有限公司

  公开号：CN112028891B

  公开（公告）日：2022-07-05

  本发明提供了一种式(I)化合物及其药物组合物。本发明的式(I)化合物可用作腺苷受体抑制剂，尤其是A2A和/或A2B抑制剂，例如可以用于预防或治疗与A2A和/或A2B活性或表达量相关的疾病。
• Enantioselective synthesis of tunable chiral pyridine–aminophosphine ligands and their applications in asymmetric hydrogenation
  作者：Youran Liu、Fei Chen、Yan-Mei He、Chenghao Li、Qing-Hua Fan

  DOI：10.1039/c9ob00770a

  日期：——

  ligands were enantioselectively synthesized based on chiral 2-(pyridin-2-yl)-substituted 1,2,3,4-tetrahydroquinoline scaffolds, which were obtained in high yields and with excellent enantioselectivities via ruthenium-catalyzed asymmetric hydrogenation of 2-(pyridin-2-yl)quinolines. The protocol features a wide substrate scope and mild reaction conditions, enabling scalable synthesis. These chiral

  基于手性2-（吡啶-2-基）-取代的1,2,3,4-四氢喹啉骨架，对映选择性地合成了一个可调谐的手性吡啶-氨基膦配体的小型文库，该文库以高收率和优异的对映选择性通过钌催化的2-（吡啶-2-基）喹啉不对称氢化。该方案具有广泛的底物范围和温和的反应条件，可实现可扩展的合成。这些手性P，N配体已成功应用于Ir催化的基准烯烃和具有挑战性的七元环亚胺（包括苯并ze庚因和苯并二氮杂卓）的不对称加氢反应。在2,4-二芳基-3 H-苯并[ b ]氮杂和2,4-不对称氢化反应中，具有出色的对映和非对映选择性（高达99％ee和> 20：1 dr）和/或前所未有的化学选择性。二芳基-3 H-苯并[ b ] [1,4]二氮杂pine。
• Unsymmetrical triazolyl-naphthyridinyl-pyridine bridged highly active copper complexes supported on reduced graphene oxide and their application in water
  作者：Wenkang Hu、Yilin Zhang、Haiyan Zhu、Dongdong Ye、Dawei Wang

  DOI：10.1039/c9gc02086a

  日期：——

  A novel unsymmetrical triazolyl-naphthyridinyl-pyridine ligand was designed and synthesized, and employed in the synthesis of a heterogeneous copper complex on reduced graphene oxide. The resulting copper composite was characterized by scanning electron microscopy (SEM), transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS) and energy dispersive X-ray spectroscopy (EDX). This

  设计并合成了一种新型的不对称三唑基-萘啶基-吡啶配体，并将其用于在氧化石墨烯上合成异质铜配合物。通过扫描电子显微镜（SEM），透射电子显微镜（TEM），X射线光电子能谱（XPS）和能量色散X射线能谱（EDX）来表征所得的铜复合材料。该包含不对称三唑基-萘啶基-吡啶（仅0.1mol％）的负载型铜催化剂在水中具有优异的催化活性，并具有良好的再循环性。通过绿色策略在水中成功地合成了各种功能化的喹啉衍生物。其他杂环化合物，例如吡啶，2-（吡啶-2-基）喹啉，1,8-萘啶，5,6-二氢萘[1,2- b在水中以超过80％的产率获得了] [1,8]萘啶和2-（吡啶-2-基）-1,8-萘啶衍生物。机理研究表明，这种转化是通过脱氢，缩合以及转移加氢和脱氢过程而发生的，氘标记实验支持了这一过程。
• Engaging electronic effects for atropselective [5+2]-photocycloaddition of maleimides
  作者：Ramya Raghunathan、Elango Kumarasamy、Steffen Jockusch、Angel Ugrinov、J. Sivaguru

  DOI：10.1039/c6cc02962k

  日期：——

  Atropisomeric maleimides were synthesized and subjected to atropselective [5+2]-photocycloaddition under direct irradiation to yield azepinone products with high enantio- (ee >98%) and diastereoselectivity (dr >98%).

  异构的马来酰亚胺被合成并在直接照射下经历异构选择性的[5+2]-光环加成反应，产生具有高对映选择性（ee >98%）和非对映选择性（dr >98%）的环庚酮产物。
• Highly Diastereo- and Enantioselective Ir-Catalyzed Hydrogenation of 2,3-Disubstituted Quinolines with Structurally Fine-Tuned Phosphine–Phosphoramidite Ligands
  作者：Xin-Hu Hu、Xiang-Ping Hu

  DOI：10.1021/acs.orglett.9b03925

  日期：2019.12.20

  diastereo- and enantioselective Ir-catalyzed hydrogenation of unfunctionalized 2,3-disubstituted quinolines, especially 3-alkyl-2-arylquinolines, has been realized. The success of this hydrogenation is ascribed to the use of a structurally fine-tuned chiral phosphine-phosphoramidite ligand with a (Sa)-3,3'-dimethyl H8-naphthyl moiety and (Rc)-1-phenylethylamine backbone. The hydrogenation displayed broad

  已经实现了高度非对映和对映选择性的Ir催化的未官能化的2，3-二取代喹啉，特别是3-烷基-2-芳基喹啉的氢化。该氢化的成功归因于使用具有（Sa）-3，3'-二甲基H8-萘基部分和（Rc）-1-苯基乙胺主链的结构精细调节的手性膦-次膦酸酯配体。氢化显示出宽泛的官能团耐受性，因此可提供高达96％ee的多种旋光性2,3-二取代的四氢喹啉，并具有完美的顺-非对映选择性。

表征谱图